Holmdahl Meirav, Ahlfors Stefan R, Holmdahl Rikard, Hansson Christer
Department of Dermatology, Lund University Hospital, SE-221 85 Lund, Sweden.
Chem Res Toxicol. 2008 Aug;21(8):1514-23. doi: 10.1021/tx8001077. Epub 2008 Jul 11.
Allergic contact dermatitis (ACD) is mediated by T cells that specifically recognize hapten-modified peptides. T cells are known to recognize antigens as short processed peptides bound to major histocompatibility complex (MHC) molecules on the surface of antigen-presenting cells (APC). It has previously been demonstrated that T cells can specifically recognize carbohydrates on the lysine at position 264 of the immunodominant (256-273) sequence from type II collagen (CII) and that such recognition is critical for the development of arthritis in mice and may play a role in rheumatoid arthritis in humans. In the present study, we have used this approach in modeling ACD, but instead of the carbohydrate, the strong sensitizer 2,4-dinitrofluorobenzene (DNFB) is bound to the epsilon-amine of the lysine at position 264. Specific T-cell hybridomas of this antigenic peptide, with dinitrophenyl (Dnp) on the epsilon-amine of lysine at position 264 (CIILysDnp 3), were established from mice immunized with CIILysDnp 3. In an immune response assay, these T-cell hybridomas were tested with a series of new synthetic hapten-modified peptides, all chemically identical except for the stereochemimistry (D, L) and the length of the position-264 amino acid side chain bonding the hapten. The T-cell hybridomas recognized the CIILysDnp 3 peptide used for immunization; interestingly, they also recognized the CII peptide with a one-carbon-longer side chain (homolysine), CIIhLysDnp 6, and CIIAlaPipDnp 11, having a ring structure analogous to that of lysine with the same number of carbons in the bonding chain as in the CIILysDnp 3 peptide used for immunization. Dnp-modified CII peptides with a shorter bonding chain produced no immune response. These data demonstrate that the T-cell recognition of the Dnp-modified peptides is highly specific and moreover dependent on the length of the amino acid side chain that bonds the Dnp.
过敏性接触性皮炎(ACD)由特异性识别半抗原修饰肽段的T细胞介导。已知T细胞将抗原识别为与抗原呈递细胞(APC)表面主要组织相容性复合体(MHC)分子结合的短加工肽段。此前已证明,T细胞可特异性识别来自II型胶原(CII)免疫显性(256 - 273)序列第264位赖氨酸上的碳水化合物,且这种识别对小鼠关节炎的发展至关重要,可能在人类类风湿关节炎中起作用。在本研究中,我们采用这种方法建立ACD模型,但用强致敏剂2,4 - 二硝基氟苯(DNFB)替代碳水化合物与第264位赖氨酸的ε - 氨基结合。用CIILysDnp 3免疫小鼠后建立了该抗原肽的特异性T细胞杂交瘤,其赖氨酸第264位ε - 氨基上带有二硝基苯基(Dnp)(CIILysDnp 3)。在免疫反应测定中,用一系列新的合成半抗原修饰肽段检测这些T细胞杂交瘤,除立体化学(D,L)和连接半抗原的第264位氨基酸侧链长度外,所有肽段化学性质相同。T细胞杂交瘤识别用于免疫的CIILysDnp 3肽段;有趣的是,它们还识别侧链长一个碳原子的CII肽段(高赖氨酸)CIIhLysDnp 6,以及CIIAlaPipDnp 11,其具有与用于免疫的CIILysDnp 3肽段中连接链碳原子数相同的类似于赖氨酸的环状结构。连接链较短的Dnp修饰CII肽段未产生免疫反应。这些数据表明,T细胞对Dnp修饰肽段的识别具有高度特异性,而且依赖于连接Dnp的氨基酸侧链长度。